Elucid’s Plaque-IQ image analysis software is now reportable under Category I Current Procedural Terminology (CPT) code 75577.
Effective January 1, 2026, the development underscores the clinical value of quantitative coronary plaque analysis and establishes favorable conditions for broader adoption of the technology, according to Elucid. The firm said payers Aetna, Humana, Cigna, and UnitedHealthcare have all aligned with coverage.
Plaque-IQ image analysis software is intended to support qualified clinicians in the noninvasive evaluation and assessment of atherosclerotic plaque as derived from analysis of coronary CT angiography (CCTA). The firm highlighted the national payment amount of $1,012 for use in imaging centers and physician offices and $951 for use in hospital outpatient settings.
![Axial images from unenhanced calcium score cardiac CT (left) and curved planar reformation images from CT angiography (right) show that higher long-term exposure to air pollution is associated with greater coronary artery calcium and more obstructive coronary artery disease (CAD). Top row: Images in a 68-year-old male patient with higher 10-year mean ambient air pollution exposure (7.9 μg/m3 for particulate matter measuring ≤2.5 μm in diameter [PM2.5] and 17.4 parts per billion [ppb] for NO2) with extensive CAD (coronary artery calcium score [CACS] >1,000 and obstructive CAD [≥70% diameter stenosis]). Bottom row: Images in a 57-year-old female patient with lower 10-year mean ambient air pollution exposure (6.3 μg/m3 for PM2.5 and 4.6 ppb for NO2) with no CAD (CACS = 0 and no obstructive stenosis).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/hanneman.r6SMLzkezo.png?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
